Physician profile
William S Ashe
NPI 1891801262
$6,178.30
in general payments reported to CMS, 2019-2025
35 companies · $1,010 in 2025
The $1,010 reported for 2025 was more than what 88% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,052 · 2020: $787 · 2021: $621 · 2022: $863 · 2023: $830 · 2024: $1,015 · 2025: $1,010.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,855.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,310.42 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,078.94 | 2019-2025 | Dupixent |
| Astrazeneca Pharmaceuticals Lp | $842.80 | 2019-2025 | Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $372.15 | 2019-2025 | Nucala |
| Aytu Biopharma, INC. | $340.23 | 2019-2025 | Karbinal |
| Covis Pharma Gmbh | $270.19 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $261.35 | 2019-2025 | |
| Pfizer INC. | $240.97 | 2019-2022 | |
| Kaleo, INC. | $161.07 | 2019-2024 | Auvi-Q |
| Integra Lifesciences Corporation | $150.00 | 2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Ars Pharmaceuticals Operations, INC. | $145.89 | 2025 | Neffy |
| Csl Behring | $118.86 | 2019-2023 | Haegarda |
| Aerin Medical INC. | $118.54 | 2024 | |
| Gilead Sciences, INC. | $108.34 | 2019-2021 | |
| Alk-Abello, INC | $90.28 | 2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $78.51 | 2019-2024 | Xolair |
| Optinose US, INC. | $67.13 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $52.50 | 2021-2023 | |
| Amgen INC. | $33.58 | 2022-2025 | Tezspire |
| Philips North America LLC | $32.46 | 2019-2022 | |
| Grifols USA, LLC | $31.00 | 2019-2020 | |
| Hikma Pharmaceuticals USA | $30.17 | 2022-2025 | Ryaltris |
| Biocryst US Sales Co., LLC | $27.80 | 2022 | |
| Dermavant Sciences, INC. | $25.85 | 2024 | Vtama |
| Abbvie INC. | $25.57 | 2019 | |
| Siemens Medical Solutions USA, INC. | $21.16 | 2025 | Immulite 1000 Immunoassay System |
| Ironshore Pharmaceuticals INC. | $20.25 | 2023 | Jornay Pm |
| Uswm, LLC | $19.00 | 2021 | |
| Circassia INC. | $18.91 | 2019 | |
| Chiesi USA, INC. | $16.30 | 2019 | |
| Mylan Specialty L.P. | $16.00 | 2019 | |
| Phadia US INC. | $14.54 | 2025 | Immunocap |
| Aimmune Therapeutics, INC. | $13.46 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $12.28 | 2021 | |
| Neos Therapeutics, Lp | $11.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Ashe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.